Author Archives: Administrator

Reven selects a United States based CMO to handle drug GMP drug manufacturing and development.

Phase 1 protocol approved by the IRB giving Reven the green light for their Phase 1 study in San Antonio.

Reven Hires Vincent Vanderbent. Vincent Vanderbent hired as Reven’s Director of Corporate Communications.

Dr. Scott E. Woodman joins Reven’s Advisory Board   Click Here for CV – SCOTT_WOODMAN_CV_05_06_2018

Reven Selects CRO for Phase 1 study in United States.

Reven received approval for first patent allowance in Japan.

Reven received approval for first patent allowance in China.

Dr. William A. Gray joins Medical Advisory Board.   Click here for CV – DrWilliamGray

Dr. Joshua A. Beckman joins Reven’s Medical Advisory Board.   Click here for CV – DrJoshuaBeckman

Dr. Daniel G. Clair joins Reven’s Medical Advisory Board.   Click here for CV –DrDanielClair

Reven launches new website www.reven.com

Dr. Robert J Kowalski joins Medical Advisory Board Click Here for CV – DrRobertKowalski

Dr. Jürgen Lüders joins Medical Advisory Board. Click here for CV – DrJurgenLuders

Reven Hires Curt Kadelbach. Curt Kadelbach hired as Senior Project Manager.

Reven Files Family Two Divisional Patent in US.